English Polski
Vol 16, No 6 (2021)
Original paper
Published online: 2021-12-31

open access

Page views 6445
Article views/downloads 354
Get Citation

Connect on Social Media

Connect on Social Media

Transcatheter closure of congenital and acquired Gerbode defects with Nit-Occlud Le VSD (PFM) Coil. Immediate and mid-term results.

Piotr Weryński1, Robert Sabiniewicz2, Paweł Skorek1, Agnieszka Wójcik1, Andrzej Rudziński1
Folia Cardiologica 2021;16(6):369-376.

Abstract

Introduction: Left ventricle-to-right atrial (LV-RA) communications termed Gerbode defects are a special and very rare type of ventricular septal defects. Transcatheter closure using Nit-Occlud Le VSD-coils is a new and not well-known alternative to cardiac surgery in selected cases. The aim of our study was to describe results and our experience with interventional closure of Gerbode defects using Nit-Occlud Le VSD-Coil. Material and Methods: The procedures were performed between October 2014 and October 2018. Patients were selected based on detailed transthoracic echocardiography (TTE). The diameter of the defects based on the TTE study was verified and comparable to values found in the angiocardiography. Despite of the fluoroscopy guidance the intraprocedural transesophageal echocardiography was carried out in every case. Finally, the effectiveness of the procedure and the occurrence of complications during the observation were assessed in each case. Results: The study involved eight children, including an infant with native Gerbode defect and seven older children with acquired post-operative LV-RA shunts. Age ranged from 8 months to 17.8 years, body weight from 7.4 kg to 56 kg, body weight from 7.4 kg to 56 kg, 5/8 females. The diameter mean of the defects in the angiocardiography was 3.86±0.82 mm and it was comparable to values from TTE. All procedures were successful. The coils ranged from 8x6 mm to 12x6 mm. Early complications after procedure: one case of a transient haemolysis which required blood transfusion and steroids, one case of temporary arrhythmia. The follow-up period ranged 2-36 months, with only one case of a permanent small residual shunt was observed. Conclusions: The interventional treatment of very rare Gerbode defect seems to be a safe alternative to surgery in selected cases. This study is one of the largest suchlike published.

Article available in PDF format

View PDF Download PDF file

References

  1. Gerbode F, Hultgren H, Melrose D. Syndrome of left ventricular-right atrial shunt; successful surgical repair of defect in five cases, with observation of bradycardia on closure. Ann Surg. 1958; 148(3): 433–446.
  2. Yuan SM. Left ventricular to right atrial shunt (Gerbode defect): congenital versus acquired. Post Kardiol Interw. 2014; 10(3): 185–194.
  3. Shi-min YA. Systematic review of acquired left ventricle to right atrium shunts (Gerbode defects. Hellenic J Cardiol. 2015; 56: 357–372.
  4. Sinisalo JP, Sreeram N, Jokinen E, et al. Acquired left ventricular-right atrium shunts. Eur J Cardiothorac Surg. 2011; 39(4): 500–506.
  5. Prifti E, Ademaj F, Baboci A, et al. Acquired Gerbode defect following endocarditis of the tricuspid valve: a case report and literature review. J Cardiothorac Surg. 2015; 10: 115.
  6. Riemenschneider TA, Moss AJ. Left ventricular-right atrial communication. Am J Cardiol. 1967; 19(5): 710–718.
  7. Sakakibara S, Konno S. Left ventricular — right atrial communication. Ann Surg. 1963; 158(1): 93–99.
  8. Kelle AM, Young L, Kaushal S, et al. The Gerbode defect: the significance of a left ventricular to right atrial shunt. Cardiol Young. 2009; 19(S2): 96–99.
  9. Kerst G, Moysich A, Ho SY, et al. Transcatheter closure of perimembranous ventricular septal defects with left ventricular to right atrial shunt. Pediatr Cardiol. 2015; 36(7): 1386–1392.
  10. Vijayalakshmi IB, Natraj Setty HS, Chitra N, et al. Amplatzer duct occluder II for closure of congenital Gerbode defects. Catheter Cardiovasc Interv. 2015; 86(6): 1057–1062.
  11. Abdi S, Momtahen M, Shafe O. Transcatheter closure of iatrogenic Gerbode defect with an Amplatzer duct occluder in a 23-year-old patient. J Cardiol Cases. 2015; 12(2): 45–47.
  12. Haas NA, Kock L, Bertram H, et al. Interventional VSD-closure with the Nit-Occlud Lê VSD-Coil in 110 patients: early and Midterm results of the EUREVECO-Registry. Pediatr Cardiol. 2017; 38(2): 215–227.
  13. Thurnam J. On aneurisms of the heart with cases. Med Chir Trans. 1838; 21: 187–438.9.
  14. Meyer H. Ueber angeborene Enge oder Verschluss der Lungenarterienbahn. Virchows Archivs Path Anat. 1857; 12(6): 497–538.
  15. Kirby CK, Johnson J, Zinsser HF. Successful closure of a left ventricular-right atrial shunt. Ann Surg. 1957; 145(3): 392–394.
  16. Trehan V, Ramakrishnan S, Goyal NK. Successful device closure of an acquired Gerbode defect. Catheter Cardiovasc Interv. 2006; 68(6): 942–945.
  17. Dangol A, Bansal M, Al-Khatib Y. Transcatheter closure of acquired left ventricle-to-right atrium shunt: first case report in an infant and review of the literature. Pediatr Cardiol. 2013; 34(5): 1258–1260.
  18. Lê TP, Vaessen P, Freudenthal F, et al. Transcatheter closure of subaortic ventricular septal defect (VSD) using a nickel–titanium spiral coil (NitOcclud): animal study and initial clinical results. Prog Pediatr Cardiol. 2001; 14(1): 83–88.
  19. Odemis E, Saygi M, Guzeltas A, et al. Transcatheter closure of perimembranous ventricular septal defects using Nit-Occlud(®) Lê VSD coil: early and mid-term results. Pediatr Cardiol. 2014; 35(5): 817–823.
  20. Saygı M, Şengül FS, Tanıdır İC, et al. Management of intractable hemolysis after transcatheter ventricular septal defect closure with Nit Occlud® Lê Coil. Turkish Journal of Thoracic and Cardiovascular Surgery. 2016; 24(1): 137–140.
  21. Rothman A, Galindo A, Channick R, et al. Amplatzer device closure of a tortuous Gerbode (left ventricle-to-right atrium) defect complicated by transient hemolysis in an octogenarian. J Invasive Cardiol. 2008; 20(9): E273–E276 .
  22. Spence MS, Thomson JD, Weber N, et al. Transient renal failure due to hemolysis following transcatheter closure of a muscular VSD using an Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv. 2006; 67(5): 663–667.